4EL-11282-92711
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-10
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-11
- 2021-09-08
-
2021-11-01
Dose 2 — Moderna
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
-
2021-11-17
Survey response — day 14, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold-like symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2022-01-31
- 2022-05-02
-
2022-09-22
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-02
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-29
- 2022-11-03
- 2022-12-24
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-01 | Moderna | No |
| 3 | 2022-09-22 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 14, dose 2
Symptoms: Cold-like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release